Loading insider details...
Beta
Latest Form 4 (May 28, 2026): Grant/Award of 8,000 VIR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| May 22, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 671 | n/a |
| Jun 2, 2025 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| May 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 775 | n/a |
| Jun 3, 2024 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| May 20, 2024 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 5,228 | n/a |
| Jul 3, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 933,317 | n/a |
| May 24, 2023 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 6,027 | n/a |
| May 19, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,454 | n/a |
| Mar 2, 2023 | Vir Biotechnology, Inc. (VIR) | Purchase | 2,500 | $56.8K |